Quick answer: In 2026, GLP-1 weight loss in India costs as little as ~₹1,300/month for generic semaglutide and up to ~₹25,781/month for high-dose Mounjaro (tirzepatide). Your total depends on the medicine, the dose you reach, and whether you choose medication alone or a full doctor-led program with coaching, diagnostics and follow-up.
What goes into the cost of a GLP-1 program?
The headline number isn't just the injection. A complete, safe program typically includes: the medication itself, an initial clinical consultation, baseline lab tests, and ongoing support (coaching, nutrition, follow-ups). Skipping the support is cheaper up front but raises the risk of muscle loss and weight regain.
GLP-1 medication cost by type (India, 2026)
Does insurance cover GLP-1 weight loss in India?
Most weight-loss prescriptions are paid out of pocket in India. That's why MetaFit uses transparent, direct-to-consumer pricing with no insurance required — so you know your monthly cost up front, with no bureaucratic hurdles.
How can you keep GLP-1 weight loss affordable?
- Generics first: approved generic semaglutide offers strong results at a fraction of branded cost.
- Right dose, not max dose: a clinician titrates to the lowest effective dose, which also lowers monthly spend.
- Protect your results: protein and strength training reduce muscle loss and regain — so you're not paying twice.
Compare specific options in our Mounjaro cost guide and semaglutide guide, or check eligibility with a free assessment. New to all this? Start with the complete GLP-1 weight loss guide for India.
Explore the topic
- GLP-1 weight loss in India
The complete guide to GLP-1 therapy, results and safety for Indian patients.
- MetaFit pricing
What the programme costs, and what your subscription does and does not cover.
- Check your GLP-1 eligibility
Find out whether doctor-supervised GLP-1 therapy is clinically appropriate for you.
References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 2021 (STEP 1) — mean 14.9% body-weight reduction at 68 weeks.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 2022 (SURMOUNT-1) — up to 20.9% body-weight reduction at 72 weeks.
This article is for general information and is not a substitute for individual medical advice. Prescription medicines referenced here are regulated in India by the Central Drugs Standard Control Organisation (CDSCO) and are dispensed only against a valid prescription from a registered medical practitioner.
Ready to Start Your Weight Loss Journey?
Get a personalized medical assessment from MetaFit's expert doctors — tailored for the Indian lifestyle.
Book a Free ConsultationOr download the app to get started
